INFLECTRA® was the first EMA-approved biosimilar of infliximab infusion therapy1
INFLECTRA® infusion therapy has been evaluated across a range of studies
Pfizer has a range of resources available to support you and your patients
Legal Category: S1A
Further information is available upon request
The information contained on this site is reserved exclusively for healthcare professionals resident in the Republic of Ireland.
I confirm that I am a healthcare professional resident in the Republic of Ireland.*
If you select 'No', you will be redirected to Pfizer.ie, where you will be able to access information on Pfizer Healthcare Ireland.
PP-UNP-IRL-0176. January 2023